D-0173-2021 Class II Terminated

Recalled by Ascend Laboratories LLC — Parsippany, NJ

FDA drug recall D-0173-2021 was initiated by Ascend Laboratories LLC on Nov 24, 2020 and is designated Class II. Reason for recall: Failed Dissolution Specifications; Out of Specification (low) results were obtained. The recall status is terminated (terminated Apr 11, 2023). Affected quantity: 1200 bottles.

Recall details

Product Type
Drugs
Report Date
Dec 9, 2020
Initiation Date
Nov 24, 2020
Termination Date
Apr 11, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1200 bottles

Product description

Tizanidine Tablets, USP 4mg, Rx Only, 150 Tablets per Bottle, Manufactured by Alkem Laboratories Ltd, Mumbai - 400 013, INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC: 67877-614-15.

Reason for recall

Failed Dissolution Specifications; Out of Specification (low) results were obtained.

Distribution pattern

MI

Code information

Lot #19143017, Exp. 05/31/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0173-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0173-2021. Report a data issue: hello@regdatalab.com.